Patients will need a syringe to self-administer this new version of Zepbound.
Elie Lilly announced this Tuesday a cheaper version of their weight loss drug, Zepboundin an effort to reach patients in the United States whose insurance doesn't cover the cost of the popular shot. The group is posting this
To continue reading, go Premium
Try it for €1 for the first month
and enjoy unlimited access to all of Expansion's web content
Or sign up with your Google account in two clicks